Intestinal Dissolution is a pharmaceutical process in which an enteric-coated capsule undergoes disintegration and release of its active ingredient specifically in the intestinal environment due to its pH-dependent or time-delayed coating properties.
184
Publications
8.8K
Citations
776
Authors
244
Institutions
Publications per year
2017–2026
37
Parents
Publications
184
1–5 of 184
Authors
776
- JD
7
h-index
- PA
6
h-index
- CR
6
h-index
- GL
5
h-index
- AW
5
h-index
1–5 of 776
Institutions
244
University of Michigan
Ann Arbor, United States
9 h-index
56 publications
2.7K citations
KU Leuven
Leuven, Belgium
7 h-index
34 publications
1.5K citations
Goethe University Frankfurt
Frankfurt am Main, Germany
7 h-index
14 publications
3.8K citations
National and Kapodistrian University of Athens
Athens, Greece
7 h-index
17 publications
1.4K citations
University of Alberta
Edmonton, Canada
6 h-index
12 publications
500 citations
Johannes Gutenberg University Mainz
Mainz, Germany
6 h-index
14 publications
544 citations
Columbia University
New York, United States
4 h-index
13 publications
2.1K citations
University of Copenhagen
Copenhagen, Denmark
4 h-index
15 publications
501 citations
1–8 of 244
Venues
- International Journal of Pharmaceutics
24 publications · 991 citations
20
h-index
- Journal of Pharmaceutical Sciences
15 publications · 1K citations
14
h-index
- Journal of Controlled Release
13 publications · 712 citations
13
h-index
- Pharmaceutical Research
10 publications · 1.6K citations
10
h-index
- European Journal of Pharmaceutics and Biopharmaceutics
EJPB · 10 publications · 609 citations
10
h-index
1–5